Urokinase-Green Cross Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Bleeding tendency: Patients receiving treatment should be observed cautiously, as cerebral or gastrointestinal hemorrhage, hematuria or gingival hemorrhage may occur rarely. In the event of serious complications such as cerebral or gastrointestinal hemorrhage, treatment should be discontinued and appropriate measures taken.
Shock: Shock symptoms may occur rarely, so close observation is necessary. In the event of any shock-related signs or symptoms such as lowered blood pressure, dyspnea, intrathoracic distress, disturbed pulse or sweating, therapy should be discontinued and appropriate steps taken.
Hypersensitivity: Hypersensitivity reactions such as rash and urticaria may occur rarely. Administration should be discontinued if there are such signs.
Hepatic: Elevated levels of S-GOT or S-GPT may occur rarely.
Gastrointestinal: Nausea, vomiting and anorexia may occur rarely.
Others: Fever, chill, headache and malaise may occur rarely.

View ADR Monitoring Form

Urokinase-Green Cross Adverse Reactions

urokinase

Manufacturer:

Taiwan Green Cross

Distributor:

Grifols Asia Pacific